GlassScriptPhysician profile
Amarinthia Curtis
NPI 1376715581
$249.57
in general payments reported to CMS, 2019-2025
10 companies · $94.58 in 2025
The $94.58 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.88 · 2020: $15.81 · 2022: $34.05 · 2024: $67.25 · 2025: $94.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $65.49 | 2020-2025 | Optune Gio, Optune |
| Janssen Biotech, INC. | $39.60 | 2025 | Carvykti, Rybrevant |
| Ge Healthcare | $34.70 | 2024 | |
| Merck Sharp & Dohme LLC | $23.46 | 2025 | Keytruda |
| Siemens Medical Solutions USA, INC. | $18.31 | 2022 | |
| Pfizer INC. | $15.74 | 2022 | |
| Celgene Corporation | $14.39 | 2024 | Reblozyl |
| Accuray Incorporated | $13.39 | 2019 | |
| Kyowa Kirin, INC. | $12.94 | 2019 | |
| Array Biopharma INC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amarinthia Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.